PE, pulmonary embolism, thrombolysis, Ekos, Ekosonic

The continuity within clinical conference topics from year to year and how presentations augment one another tells us a lot about where medicine is headed. Pulmonary embolism (PE) therapies were a key subject presented at the 2013 and 2014 Veith Symposium meetings in New York. 
 

The U.S. Food and Drug Administration (FDA) has approved the Xarelto Starter Pack for deep vein thrombosis (DVT) and/or pulmonary embolism (PE) treatment. The starter pack was designed to help simplify the dosing for the initial 30-day treatment period when patients are at greatest risk of having another DVT or PE.

Biotronik announced that results of its BIOLUX P-I clinical study have been published in the Journal of Endovascular Therapy. BIOLUX P-I was a prospective, international, multi-center, first-in-human, randomized, controlled trial that enrolled 60 patients at five centers in Germany and Austria. The study assessed the safety and efficacy of the Passeo-18 Lux drug-coated balloon (DCB) in treating de novo and restenotic femoropopliteal lesions. The positive results were instrumental in gaining CE mark in December 2013.

TomTec Imaging Systems GmbH introduced AutoStrain software for automated strain analysis and quantitative visualization of left ventricular function at the 64th Annual Scientific Session of the American College of Cardiology (ACC 2015) in San Diego.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now